CXCL10 and tuberculosis: In a multicenter study conducted in Europe in the patients with non-tuberculosis disease, IP-10 was 35% positive and QFT-GIT test was 27% positive and increase in the positivity of IP-10 was interpreted in the way that IP-10 might have superior sensitivity or impaired specificity as compared to QFT-GIT [25].